# Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

> **NCT01174940** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 22 (actual)

## Conditions studied

- Stem Cell Leukemia of Unclear Lineage
- Graft Versus Host Disease

## Interventions

- **DRUG:** extracorporeal photopheresis

## Key facts

- **NCT ID:** NCT01174940
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2014-08
- **Final completion:** 2015-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174940, "Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01174940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*